GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Insider Ownership

SynBiotic SE (XTER:SBX) Insider Ownership : 0.00 % (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SynBiotic SE's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SynBiotic SE's Institutional Ownership is 0.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SynBiotic SE's Float Percentage Of Total Shares Outstanding is 0.00%.


SynBiotic SE Insider Ownership Historical Data

The historical data trend for SynBiotic SE's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Insider Ownership Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Insider Ownership
Get a 7-Day Free Trial - - - - -

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Insider Ownership Get a 7-Day Free Trial Premium Member Only - - - - -

SynBiotic SE Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


SynBiotic SE Business Description

Traded in Other Exchanges
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines